VANGUARD GROUP INC - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is ASTWS and the CUSIP is 04624N115. A total of 3 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2017$45,000
+15.4%
89,7770.0%0.00%
Q1 2017$39,000
-20.4%
89,7770.0%0.00%
Q4 2016$49,000
+8.9%
89,7770.0%0.00%
Q3 2016$45,000
+150.0%
89,7770.0%0.00%
Q2 2016$18,00089,7770.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 328,205$179,0000.03%
Manatuck Hill Partners, LLC 75,000$41,0000.02%
ROYAL BANK OF CANADA 8$00.00%
Creative Planning 128$00.00%
VANGUARD GROUP INC 89,777$49,0000.00%
Chicago Partners Investment Group LLC 3$00.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 134$00.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 4,423$2,0000.00%
UBS Group AG 813$00.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 29,609$16,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders